Optimization and clinical validation of a pathogen detection microarray
2007

Optimizing Pathogen Detection with Microarrays

Sample size: 36 publication 10 minutes Evidence: high

Author Information

Author(s): Christopher W Wong, Charlie Lee Wah Heng, Yee Leong Wan, Shirlena WL Soh, Cissy B Kartasasmita, Eric AF Simoes, Martin L Hibberd, Wing-Kin Sung, Lance D Miller

Primary Institution: Genome Institute of Singapore

Hypothesis

Can a customized microarray platform improve the detection of various pathogens in clinical samples?

Conclusion

The study demonstrates that a new microarray platform can accurately identify pathogens with high sensitivity and specificity.

Supporting Evidence

  • The microarray identified pathogens with 94% accuracy.
  • The platform showed 76% sensitivity and 100% specificity.
  • Microarrays can reduce the time for diagnosis to 2-6 hours.
  • Customized algorithms improved PCR primer design.
  • Cross-hybridization was minimized to enhance detection accuracy.
  • Statistical methods were developed to infer pathogen identity.
  • Clinical samples were analyzed in a blinded fashion.
  • Results were validated against real-time PCR outcomes.

Takeaway

Scientists created a special test that can find germs in sick kids' noses really well, helping doctors know what's making them sick.

Methodology

The study involved designing a microarray to detect 35 RNA viruses, testing it on clinical samples, and comparing results with real-time PCR.

Potential Biases

Potential biases in PCR amplification could affect the accuracy of pathogen detection.

Limitations

The microarray may not detect all strains of viruses due to genetic variations.

Participant Demographics

Children under 4 years of age with lower respiratory tract infections.

Statistical Information

P-Value

2.2 × 10-16

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/gb-2007-8-5-r93

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication